Wednesday, 26 July 2017 10:14

ASM Addresses Palmetto Lab Testing Reimbursement

ASM has joined other societies with expertise in diagnostic testing in a letter addressing the Palmetto Draft Local Coverage Determination of Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs). Palmetto, a contractor in the Southeast US for the Centers of Medicare and Medicaid Services, has indicated that it will not reimburse syndromic panels for identification  of respiratory and gastrointestinal pathogens.  ASM and co-signers indicate clear uses of these panels in improving patient care in the letters, submitted on July 20.

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

6708:pal-test